New Medicare Part B Immunosuppressant Drug Benefit (PBID) - Implementation
The purpose of this Change Request (CR) is to outline the changes needed and directives to the downstream systems when implementing the new Part B immunosuppressive drug (PBID) benefit. This CR also updates certain sections in Pub. 100-01, 100-02, and 100-04 with policy and claims processing information regarding the new PBID benefit.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: December 22, 2022
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.